MSB 3.21% $1.13 mesoblast limited

Whytee- you seem to forget who was being misleading. you...

  1. 2,886 Posts.
    lightbulb Created with Sketch. 2043
    Whytee- you seem to forget who was being misleading.

    you inferred that the FDA would not consider "further long term survival data" . That is false and was an attempt to discredit the 4 year results. They made reference to survival endpoints in the design- no mention of long term survival data


    Reg

 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.